Skip to main content
. 2020 Nov 19;3(11):e2025881. doi: 10.1001/jamanetworkopen.2020.25881

Figure 2. Survival Outcomes for the Subgroup Recommended for Radiotherapy (RT) and chemoradiotherapy (CRT) in the Test Cohort.

Figure 2.

Results illustrated for DeepSurv (A, B), neural network multitask logistic regression (N-MLTR) (C, D), and random survival forest (RSF) (E, F) models. Panels on the left examine the subgroup of patients who were recommended to receive radiation alone by each of the 3 models, with no survival difference (per log-rank test) seen between patients who did or did not receive chemotherapy. A benefit to chemotherapy is seen for patients recommended for CRT by the DeepSurv and N-MTLR models (B, D).